IREN
IREN Limited
There isn't enough reported data to score IREN yet.
PMTS
CPI Card Group Inc.
PMTS's fundamentals are mixed, but it looks expensive: trading at 18x earnings, above its usual 13x. Analysts expect strong earnings growth, though they disagree widely on how much.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
PMTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
PMTS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like PMTS.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
PMTS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 7.6x | $25.16 | — |
| Cheap | 7.7x | $10.50 | -58% |
| Fair | 13x | $17.47 | -31% |
| Expensive | 18x | $24.54 | -2.5% |
| Current | 18x | $25.16 | — |
Historical ranges are pointers, not guarantees.
PMTS's PE is in its expensive range at 18x. If earnings grow as analysts expect, today's price would be 7.6x next year's earnings, in its cheap range.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PMTS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
PMTS has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
PMTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.32 | +142% |
| Q3 2026 | $1.37 | +15% |
| Q2 2026 | $1.15 | +3.6% |
| Q1 2026 | $1.02 | -35% |
| Q4 2025 | $1.25 | -24% |
| Q3 2025 | $1.19 | -8.5% |
| Q2 2025 | $1.11 | -27% |
| Q1 2025 | $1.58 | +1.3% |
| Q4 2024 | $1.64 | -18% |
PMTS has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
PMTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $158.4M | +15% |
| Q2 2026 | $149.2M | +15% |
| Q1 2026 | $147.1M | +20% |
| Q4 2025 | $153.1M | +22% |
| Q3 2025 | $138M | +11% |
| Q2 2025 | $129.8M | +9.2% |
| Q1 2025 | $122.8M | +9.7% |
| Q4 2024 | $125.1M | +22% |
PMTS's revenue has grown year over year for 10 quarters in a row: $158M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.9% | +0.5 points |
| Q2 2026 | 8% | +0.7 points |
| Q1 2026 | 7.5% | -4 points |
| Q4 2025 | 12% | -0.8 points |
| Q3 2025 | 9.4% | -4.8 points |
| Q2 2025 | 7.3% | -5.3 points |
| Q1 2025 | 11% | -1.2 points |
| Q4 2024 | 13% | +2.5 points |
PMTS has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
PMTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $10.1M | +90% |
| Q2 2026 | $25.9M | +4762% |
| Q1 2026 | $10.1M | +3371% |
| Q4 2025 | $35.2M | +63% |
| Q3 2025 | $5.3M | -52% |
| Q2 2025 | $533K | +$6.5M |
| Q1 2025 | $292K | -96% |
| Q4 2024 | $21.6M | +89% |
PMTS has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
PMTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +127K shares |
| 1 year | +2.6% | +313K shares |
| 3 years | +2.9% | +339K shares |
| 5 years | +3.1% | +367K shares |
| Available history | +8.7% | +970K shares |
PMTS has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | $2.2M |
| Q2 2024 | $5.2M |
| Q1 2024 | $1.3M |
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
PMTS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.9x | Moderate |
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | High |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.1x | Elevated |
PMTS's net debt is about 2.9 years of its operating earnings (EBITDA), down from 4.0 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PMTS.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
PMTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 40.6 | Neutral |
PMTS's weekly RSI is 56 (neutral) and its Stochastic is 41 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
PMTS PE vs Financial Services Sector
| Metric | PMTS | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 41% above |
| PE % | 84 | 63 | 21 pts above |
PMTS is trading at 18x earnings, a 41% premium to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
PMTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.3 | 0.6% below |
| 20 week MA | $24.5 | 2.7% above |
| 50 week MA | $19.2 | 31% above |
| 100 week MA | $20.7 | 21% above |
| 200 week MA | $22.9 | 9.8% above |
PMTS has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
PMTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.82 | $4.25 | +418% |
| 2021 | $4.25 | $20.1 | +373% |
| 2022 | $20.1 | $35.1 | +75% |
| 2023 | $35.1 | $19.2 | -45% |
| 2024 | $19.2 | $31.9 | +66% |
| 2025 | $31.9 | $15.2 | -52% |
| 2026 YTD | $15.2 | $25.2 | +65% |
PMTS has the edge over IREN on returns for 2026, with the stronger performance.